The association between depressive symptom trajectories and risk of all-cause mortality and premature death: A 10-year follow-up study in United States and England.

Year of Publication
2025
Author
Journal
Gen Hosp Psychiatry
Volume
96
Number of Pages
97-106
ISSN Number
1873-7714
Abstract

BACKGROUND: Depression has emerged as a leading cause of disease burden and disability worldwide. This study aimed to investigate the association between depressive symptom trajectories, all-cause mortality, and premature death.

METHOD: We utilized the data from Health Retirement Study (HRS) and English Longitudinal Study of Aging (ELSA). Depressive symptoms were assessed using the 8-item CESD scale and categorized into somatic and cognitive-affective subtypes. Cox proportional risk mode was employed to estimate the relationship between depressive symptom trajectories and all-cause mortality and premature death.

RESULT: Among 17,930 enrolled participants, 4543 died, including 1063 premature deaths. Increasing total depressive symptoms had the highest risk for all-cause mortality with HR 2.01 (95 %CI: 1.72-2.35) followed by consistently high with HR 1.53 (95 %CI: 1.36-1.72) adjusted for covariates compared to consistently low. Increasing and consistently high total trajectories had elevated risks for premature death with HR 1.83 (95 %CI: 1.29-2.59) and HR 2.01 (95 %CI: 1.61-2.51). Increasing, consistently high somatic or cognitive-affective depressive symptom trajectories also increased the risks of all-cause mortality and premature death. Decreasing somatic, cognitive-affective, and total trajectories showed no higher risk for premature death (HR 1.56, 95 %CI: 0.90-2.72; HR 1.00, 95 %CI: 0.56-1.78; HR 1.17, 95 %CI: 0.76-1.81).

CONCLUSION: Increasing or consistently high trajectories of somatic, cognitive-affective, and total depressive symptoms were associated with elevated risks of all-cause mortality and premature death, whereas decreasing trajectories were not associated with increased risks. Early interventions aimed at reducing the duration of depressive symptoms may help to extend lifespan.

DOI
10.1016/j.genhosppsych.2025.06.011
PMID
40582020
Download citation